000 01304 a2200349 4500
005 20250517195654.0
264 0 _c20190821
008 201908s 0 0 eng d
022 _a2169-141X
024 7 _a10.1080/21691401.2018.1430700
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAhad, Abdul
245 0 0 _aDevelopment and biological evaluation of vesicles containing bile salt of telmisartan for the treatment of diabetic nephropathy.
_h[electronic resource]
260 _bArtificial cells, nanomedicine, and biotechnology
_c2018
300 _a532-539 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntioxidants
_xmetabolism
650 0 4 _aBile Acids and Salts
_xchemistry
650 0 4 _aBiomarkers
_xmetabolism
650 0 4 _aDiabetic Nephropathies
_xdrug therapy
650 0 4 _aDrug Compounding
650 0 4 _aOxidative Stress
_xdrug effects
650 0 4 _aRats
650 0 4 _aTelmisartan
_xchemistry
700 1 _aRaish, Mohammad
700 1 _aAhmad, Ajaz
700 1 _aAl-Jenoobi, Fahad I
700 1 _aAl-Mohizea, Abdullah M
773 0 _tArtificial cells, nanomedicine, and biotechnology
_gvol. 46
_gno. sup1
_gp. 532-539
856 4 0 _uhttps://doi.org/10.1080/21691401.2018.1430700
_zAvailable from publisher's website
999 _c28017958
_d28017958